LingVo.club
📖+10 XP
🎧+10 XP
+15 XP
How the T cell receptor starts immune attacks (Level A1) — a close up of a white substance on a blue background

How the T cell receptor starts immune attacksCEFR A1

29 Dec 2025

Level A1 – Beginner
2 min
84 words
  • T cell therapy trains the immune system to find cancer.
  • These treatments help some people but not all patients.
  • The therapy depends on a T cell receptor protein.
  • Scientists used a special microscope to view the receptor.
  • They put the receptor into a small membrane patch.
  • The resting receptor stayed closed and folded inside the membrane.
  • When it met a target molecule, it opened like a spring.
  • Assembling the membrane and proteins was hard for researchers.
  • The new view could help improve future immunotherapies.

Difficult words

  • receptora protein that receives signals on cells
  • membranea thin layer that surrounds a cell
  • microscopea tool that makes very small things bigger
  • assembleto put parts together to make something
    Assembling
  • immunethe body's system that fights germs and disease
  • targeta thing or molecule that is the aim

Tip: hover, focus or tap highlighted words in the article to see quick definitions while you read or listen.

Discussion questions

  • Have you ever seen a microscope?
  • Would you like to work in medical research?
  • Do you think new cancer treatments are important?

Related articles

AI finds new target for monkeypox (Level A1)
28 Dec 2025

AI finds new target for monkeypox

Researchers used artificial intelligence to identify a viral protein called OPG153 that many antibodies bind. Laboratory tests and mouse studies confirmed the finding, which could help develop cheaper vaccines or antibody treatments.

Aging muscle may help cancer grow (Level A1)
17 Jun 2026

Aging muscle may help cancer grow

Scientists found that older, weaker muscle releases fewer extracellular vesicles and less of a microRNA called miR-7a-5p. Exercise can restore vesicle release and may help reduce cancer risk in older adults. The work suggests new biomarkers and therapies.